J. Candy

发表

Brain iron homeostasis.

C. Morris, G. Taylor, J. Edwardson, 1992, Journal of inorganic biochemistry.

Histochemical distribution of non-haem iron in the human brain.

C. Morris, J. Edwardson, C. Bloxham, 1992, Acta anatomica.

The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS)

C. Morris, G. Taylor, J. Edwardson, 1992, Biology of the cell.

ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE

E. Perry, J. Klinowski, J. Atack, 1986, The Lancet.

Aluminium and the pathogenesis of senile plaques: studies in Alzheimer's disease and chronic renal failure

J. Edwardson, J. Candy, 1990, Environmental geochemistry and health.

Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients.

C. Morris, G. Taylor, J. Edwardson, 1992, The Biochemical journal.

Effect of aluminium on expression and processing of amyloid precursor protein

C. Morris, D. Allsop, J. Edwardson, 1996, Journal of neuroscience research.

Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure

G. Perry, K. Beyreuther, C. Martyn, 1992, Journal of the Neurological Sciences.

Co-Localization of Aluminium and Silicon in Senile Plaques: Implications for the Neurochemical Pathology of Alzheimer’s Disease

E. Perry, J. Klinowski, J. Edwardson, 1985 .

Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients

C. Morris, G. Taylor, J. Edwardson, 1989, Journal of the Neurological Sciences.

Transferrin receptors in the Parkinsonian midbrain

J. Edwardson, C. Morris, C. Bloxham, 1994, Neuropathology and applied neurobiology.

Content of Brain Aluminum Is Not Elevated in Alzheimer Disease

E. Bjertness, P. Ince, J. Edwardson, 1996, Alzheimer disease and associated disorders.

Gallium‐67 as a Potential Marker for Aluminium Transport in Rat Brain: Implications for Alzheimer's Disease

G. Taylor, J. Edwardson, J. Candy, 1990, Journal of neurochemistry.

Aluminium and the pathogenesis of senile plaques in Alzheimer's disease, Down's syndrome and chronic renal dialysis.

J. Edwardson, J. Candy, 1989, Annals of medicine.

An autoradiographic approach for studying the distribution of neurotransmitter receptor binding sites on biopsy samples of human gliomas

J. Edwardson, R. Perry, J. Candy, 1986 .

Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort.

C. Morris, E. Bjertness, P. Ince, 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

IMMUNOHISTOCHEMICAL DEMONSTRATION OF AMYLOID P COMPONENT IN CEREBRO‐VASCULAR AMYLOIDOSIS

P. D. Lewis, M. Pepys, G. Tennent, 1984, Neuropathology and applied neurobiology.

Iron uptake in the brain of the myelin-deficient rat

C. Morris, A. Gocht, J. Candy, 1993, Neuroscience Letters.

Evidence for the localization of haemopexin immunoreactivity in neurones in the human brain

C. Morris, J. Edwardson, A. Smith, 1993, Neuroscience Letters.

Brain transferrin receptors and the distribution of cytochrome oxidase.

C. Morris, J. Edwardson, C. Bloxham, 1990, Biochemical Society Transactions.

Histopathology of melanocytic lesions in goats and establishment of a melanoma cell line: a potential model for human melanoma.

P. Parsons, J. Candy, H. Takahashi, 1990, Pigment cell research.

Transferrin-gallium binding in Alzheimer's disease

J. Edwardson, A. Fairbairn, J. Candy, 1991, The Lancet.

Immunocytochemical localisation of transferrin in the human brain.

C. Morris, J. Edwardson, C. Bloxham, 1992, Acta anatomica.

Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians

C. Morris, P. Ince, E. Bjertness, 1995, Neuroscience Letters.

Glutamate deficits in Alzheimer's disease

E. Perry, P. Slater, A. Cross, 1987, Journal of neurology, neurosurgery, and psychiatry.

The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.

E. Perry, J. Edwardson, R. Perry, 1986, Progress in brain research.

Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system.

C. Morris, E. Bjertness, G. Taylor, 1992, Ciba Foundation symposium.

Distribution of neurofibrillary tangle formation and [3H]‐D‐aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease

E. Perry, J. Xuereb, E. Marshall, 1990, Neuropathology and applied neurobiology.

Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions.

E. Bjertness, P. Ince, J. Edwardson, 1995, Dementia.

Cholinergic Receptors in Cognitive Disorders

E. Perry, D. Purohit, J. Edwardson, 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Protective effect of apoE ∈2 in Alzheimer's disease

E. Bjertness, P. Ince, J. Edwardson, 1994, The Lancet.

Distribution of transferrin receptors in relation to cytochrome oxidase activity in the human spinal cord, lower brainstem and cerebellum

C. Morris, J. Edwardson, C. Bloxham, 1992, Journal of the Neurological Sciences.

Transferrin receptors in the normal human hippocampus and in Alzheimer's disease

J. Kerwin, J. Kerwin, J. Edwardson, 1994, Neuropathology and applied neurobiology.

Association of Aluminium and Silicon with Neuropathological Changes in the Ageing Brain

J. Edwardson, P. Chalker, D. Gauvreau, 1988 .

Aluminium, silicon, and the pathogenesis of senile plaques

G. Taylor, J. Edwardson, J. Candy, 1989 .

Electron microscopic appearances and implications of neuropeptide fibrillary forms

J. Candy, E. Perry, A. Oakley, 1981, Neuropeptides.